The biotech scorecard for the first quarter: 16 stock-moving events to watch
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first quarter.
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first quarter.
This study examines trends in prescribing and reimbursement for glucagon products in Medicaid before and after the introduction of these newer products.
This cohort study compares the incidence of cardiovascular disease between Medicare beneficiaries with migraine who initiated anti–calcitonin gene-related peptide (CGRP) monoclonal antibodies compared with onabotulinumtoxinA.
Objectives This work aimed to resolve the conflicting reports on Prevotellaceae abundance in the development of rheumatoid arthritis (RA) and to observe structural, functional and…
Dr. Kahn is a summa cum laude graduate of the University of Michigan School of Medicine. He practices cardiology in Detroit, is a clinical professor…
“Alison was the preeminent scholar on adolescent obesity and eating disorders,” said Kerri Boutelle, a pediatrics professor at the University of California, San Diego
The adaptable technological solution has the potential to revolutionize engineering designs. A breakthrough in artificial intelligence is making it possible to model complex systems—like how…
The covid-19 pandemic was associated with an unprecedented increase in alcohol consumption and associated morbidity, including hospitalizations for alcohol withdrawal. Clinicians based in hospitals must…
Join STAT’s biotech team in San Francisco as they take the stage to help you digest the biggest stories from the year’s JPM Healthcare Conference.
Daniel Dines is the Founder & CEO at UiPath, one of the most incredible journeys in startups. For 10 years, UiPath was a bootstrapped company…
A screening of MLK’s historic 1967 speech at Stanford kicks off a week of programming in honor of the civil rights leader’s legacy.